The novel uncompetitive NMDA receptor antagonist esmethadone (REL-1017) has no meaningful abuse potential in recreational drug users.
- Resource Type
- Article
- Authors
- Shram, Megan J.; Henningfield, Jack E.; Apseloff, Glen; Gorodetzky, Charles W.; De Martin, Sara; Vocci, Frank L.; Sapienza, Frank L.; Kosten, Thomas R.; Huston, Jeff; Buchhalter, August; Ashworth, Judy; Lanier, Ryan; Folli, Franco; Mattarei, Andrea; Guidetti, Clotilde; Comai, Stefano; O'Gorman, Cedric; Traversa, Sergio; Inturrisi, Charles E.; Manfredi, Paolo L.
- Source
- Translational Psychiatry; 6/7/2023, Vol. 13 Issue 1, p1-12, 12p
- Subject
- Language
- ISSN
- 21583188